Safety, Tolerability and Pharmacokinetics of MK-4334 in Participants With Alzheimer's Clinical Syndrome on a Stable Dose of Donepezil (MK-4334-005)
Conditions: Alzheimer's Disease; Mild Cognitive Impairment Interventions: Drug: MK-4334; Drug: Placebo to MK-4334; Drug: Donepezil Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2018 Category: Research Source Type: clinical trials
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
Conditions: Cognitive Impairment; Alzheimer Disease Interventions: Drug: THN 201; Drug: Donepezil; Drug: Placebo Sponsor: Theranexus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2018 Category: Research Source Type: clinical trials